Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail D Anderson

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Clinical Pharmacokinetics|October 15, 2013
Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairmentGail D Anderson, Shahin Hakimian
Clinical Pharmacokinetics|April 24, 2009
Effect of pregnancy on the pharmacokinetics of antihypertensive drugsGail D Anderson, Darcy B Carr
Clinical Pharmacokinetics|October 1, 2014
Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol)Lingtak-Neander Chan, Gail D Anderson
Advanced Drug Delivery Reviews|February 14, 2012
Current oral and non-oral routes of antiepileptic drug deliveryGail D Anderson, Russell P Saneto
Clinical Pharmacokinetics|April 24, 2016
Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation ProductsGail D Anderson, Lingtak-Neander Chan
CNS Drugs|September 16, 2015
Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical AspectsGail D Anderson, Russell P Saneto
Pharmacotherapy|May 30, 2009
Optimizing pediatric dosing: a developmental pharmacologic approachGail D Anderson, Anne M Lynn
Therapeutics and Clinical Risk Management|June 19, 2009
Onset of action and seizure control in Lennox-Gaustaut syndrome: focus on rufinamideRussell P Saneto, Gail D Anderson
Advances in Chronic Kidney Disease|October 20, 2004
Pharmacokinetics of estrogen and progesterone in chronic kidney diseaseGail D Anderson, Peggy S Odegard
Clinical Pharmacokinetics|July 10, 2002
Treatment of epilepsy in women of reproductive age: pharmacokinetic considerationsJames W McAuley, Gail D Anderson
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Clinical Pharmacokinetics|October 15, 2013
Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairmentGail D Anderson, Shahin Hakimian
Clinical Pharmacokinetics|April 24, 2009
Effect of pregnancy on the pharmacokinetics of antihypertensive drugsGail D Anderson, Darcy B Carr
Clinical Pharmacokinetics|October 1, 2014
Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol)Lingtak-Neander Chan, Gail D Anderson
Advanced Drug Delivery Reviews|February 14, 2012
Current oral and non-oral routes of antiepileptic drug deliveryGail D Anderson, Russell P Saneto
Clinical Pharmacokinetics|April 24, 2016
Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation ProductsGail D Anderson, Lingtak-Neander Chan
CNS Drugs|September 16, 2015
Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical AspectsGail D Anderson, Russell P Saneto
Pharmacotherapy|May 30, 2009
Optimizing pediatric dosing: a developmental pharmacologic approachGail D Anderson, Anne M Lynn
Therapeutics and Clinical Risk Management|June 19, 2009
Onset of action and seizure control in Lennox-Gaustaut syndrome: focus on rufinamideRussell P Saneto, Gail D Anderson
Advances in Chronic Kidney Disease|October 20, 2004
Pharmacokinetics of estrogen and progesterone in chronic kidney diseaseGail D Anderson, Peggy S Odegard
Clinical Pharmacokinetics|July 10, 2002
Treatment of epilepsy in women of reproductive age: pharmacokinetic considerationsJames W McAuley, Gail D Anderson
Pageof 7